ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
20.79
+0.04 (0.19%)
Mar 30, 2026, 3:21 PM EDT - Market open
ACADIA Pharmaceuticals Employees
As of December 31, 2025, ACADIA Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,342,738
Profits / Employee
$489,975
Market Cap
3.54B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Corcept Therapeutics | 730 |
| Crinetics Pharmaceuticals | 594 |
| Alumis | 224 |
| Structure Therapeutics | 220 |
| Edgewise Therapeutics | 146 |
| Spyre Therapeutics | 102 |
ACAD News
- 17 days ago - Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum - Business Wire
- 26 days ago - Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors - Business Wire
- 27 days ago - Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome - Business Wire
- 4 weeks ago - Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline Kicker - Seeking Alpha
- 4 weeks ago - ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview - Business Wire
- 4 weeks ago - Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - Business Wire
- 7 weeks ago - Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - Business Wire